{"filing":{"accession_number":"0001193125-26-333761","cik":"0001136869","ticker":"ZBH","company_name":"ZIMMER BIOMET HOLDINGS, INC.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"zbh-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312526333761/zbh-20260805.htm"},"events":[{"id":24463,"run_id":22169,"accession_number":"0001193125-26-333761","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Zimmer Biomet issued a press release on August 5, 2026, reporting second quarter 2026 financial results, including net sales of $2.177 billion (4.8% growth), diluted EPS of $1.03, and adjusted diluted EPS of $2.07. The company also updated full-year 2026 financial guidance, raising revenue and adjusted EPS projections. This is a standard quarterly earnings disclosure under Item 2.02, with the press release attached as Exhibit 99.1.","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25019,"accession_number":"0001193125-26-333761","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Zimmer Biomet issued a press release on August 5, 2026, reporting second quarter 2026 financial results, including net sales of $2.177 billion (4.8% growth), diluted EPS of $1.03, and adjusted diluted EPS of $2.07. The company also updated full-year 2026 financial guidance, raising revenue and adjusted EPS projections. This is a standard quarterly earnings disclosure under Item 2.02, with the press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:37:39.650964+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25019,"accession_number":"0001193125-26-333761","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Zimmer Biomet issued a press release on August 5, 2026, reporting second quarter 2026 financial results, including net sales of $2.177 billion (4.8% growth), diluted EPS of $1.03, and adjusted diluted EPS of $2.07. The company also updated full-year 2026 financial guidance, raising revenue and adjusted EPS projections. This is a standard quarterly earnings disclosure under Item 2.02, with the press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:37:39.650964+00:00","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-08-05"}]}